A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
Launched by PFIZER · Dec 15, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to learn more about the health outcomes of people who have COVID-19 or influenza. Researchers want to understand the symptoms these patients experience and how COVID-19 vaccines might affect their health. The study will include adults aged 18 and older who have tested positive for COVID-19 or influenza and reported at least one symptom. Participants can get tested at CVS pharmacy locations, and the researchers will follow up with them through emails over a six-month period to gather information about their health.
To be eligible for the study, participants need to be at least 18 years old, have reported symptoms, and have a confirmed positive test for COVID-19 or influenza. Participants will complete a series of questionnaires in either English or Spanish. This study is currently recruiting participants, and if you or someone you know meets the criteria, it could be a valuable opportunity to contribute to important research on COVID-19 and influenza.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 or older
- • Self-reported at least one symptom in the CVS Health pre-test screening questionnaire
- • Positive result reported from diagnostic test for COVID-19 (or influenza in updated analysis)
- • Evidence of a signed and dated informed consent through electronic consent process indicating that the participant has been informed of all pertinent aspects of the study
- • Able to complete the questionnaires by themselves in English or Spanish
- Exclusion Criteria:
- • - No symptoms reported in the study screening questionnaire
About Pfizer
Pfizer Inc. is a global leader in biopharmaceutical innovation, dedicated to discovering, developing, and delivering advanced therapies that enhance patient outcomes across a wide range of medical conditions. With a rich history of scientific research and a commitment to quality, Pfizer focuses on areas such as oncology, immunology, cardiology, and rare diseases. The company leverages cutting-edge technology and collaborates with healthcare professionals, regulatory bodies, and academic institutions to conduct rigorous clinical trials that ensure the safety and efficacy of its products. Pfizer's mission is to bring breakthroughs that change patients' lives, exemplifying its commitment to health and wellness worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Woonsocket, Rhode Island, United States
Patients applied
Trial Officials
Pfizer CT.gov Call Center
Study Director
Pfizer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials